| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $416.4K | - | |
| CFO | 26.0K | $180.4K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2016 | Yu K Peony | Chief Medical Officer | Sell | 6,107 | $17.60 | $107,483.20 | -2.8% | |
| May 16, 2016 | Cotroneo Pat | VP, Finance And CFO | Sell | 6,107 | $17.60 | $107,483.20 | -4.1% | |
| May 3, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $17.78 | $480,060.00 | -0.4% | |
| Apr 20, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $19.98 | $539,460.00 | -0.4% | |
| Apr 5, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $21.11 | $570,042.90 | -0.2% | |
| Apr 1, 2016 | Valone Frank H Md | Chief Medical Officer | Sale+OE | 10,750 | $21.11 | $226,941.20 | -4.9% | |
| Mar 22, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $18.74 | $505,872.00 | -0.2% | |
| Mar 8, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $19.62 | $529,612.62 | -0.2% | |
| Mar 1, 2016 | Valone Frank H Md | Chief Medical Officer | Sale+OE | 10,750 | $16.84 | $181,040.45 | -4.6% | |
| Feb 23, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $19.11 | $515,850.00 | -0.2% |